Azercabtagene zapreleucel (azer-cel)
TG-Azercel-101
Phase 1 small_molecule active
Quick answer
Azercabtagene zapreleucel (azer-cel) for B-cell Mediated Autoimmune Disorders is a Phase 1 program (small_molecule) at TG THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- B-cell Mediated Autoimmune Disorders
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active